中华医学会肝病学分会重型肝病与人工肝学组 , 中华医学会感染病学分会肝衰竭与人工肝学组 . 肝衰竭诊治指南(2024年版) [J ] . 临床肝胆病杂志 , 2024 , 40 ( 12 ): 2371 ‑ 2387 .

Liver Failure and Artificial Liver Group of Chinese Society of Infectious Diseases , Chinese Medical Association , Severe Liver Disease and Artificial Liver Group of Chinese Society of Hepatology , Chinese Medical Association . Guideline for diagnosis and treatment of liver failure(2024 version) [J ] . J Clin Hepatol , 2024 , 40 ( 12 ): 2371 ‑ 2387 .

Organization Committee of 13th Asia⁃Pacific Congress of Clinical Microbiology and Infection . 13th Asia‑Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure [J ] . Hepatobiliary Pancreat Dis Int , 2013 , 12 ( 4 ): 346 ‑ 354 .

BISWAS S , SHALIMAR . Definitions, etiopathogenesis and epidemiology of ALF [J ] . Best Pract Res Clin Gastroenterol , 2024 , 73 : 101959 .

MOREAU R , GAO B , PAPP M , et al . Acute‑on‑chronic liver failure: A distinct clinical syndrome [J ] . J Hepatol , 2021 , 75 : S27 ‑ S35 .

KOCH D G , TILLMAN H , DURKALSKI V , et al . Development of a model to predict transplant‑free survival of patients with acute liver failure [J ] . Clin Gastroenterol Hepatol , 2016 , 14 ( 8 ): 1199 ‑ 1206.e2 .

MAHMUD N , KAPLAN D E , TADDEI T H , et al . Incidence and mortality of acute‑on‑chronic liver failure using two definitions in patients with compensated cirrhosis [J ] . Hepatology , 2019 , 69 ( 5 ): 2150 ‑ 2163 .

WU S Q , YUE P P , MA Y S , et al . Hemoperfusion adsorbents for removal of common toxins in liver and kidney failure: Recent progress, challenges, and prospects [J ] . Adv Mater , 2025 , 37 ( 31 ): 2305152 .

MAIWALL R , KULKARNI A V , ARAB J P , et al . Acute liver failure [J ] . Lancet , 2024 , 404 ( 10454 ): 789 ‑ 802 .

TREBICKA J , AMOROS A , PITARCH C , et al . Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis [J ] . Front Immunol , 2019 , 10 : 476 .

中华人民共和国国家卫生部 . 中国人体器官分配与共享基本原则和肝脏与肾脏移植核心政策 [J ] . 实用器官移植电子杂志 , 2013 , 1 ( 2 ): 67 ‑ 71 .

Ministry of Health of the People's Republic of China . Basic principles of human organ distribution and sharing and core policy of liver and kidney transplantation in China [J ] . Pract J Organ Transplant Electron Version , 2013 , 1 ( 2 ): 67 ‑ 71 .

HERNAEZ R , LIU Y , KRAMER J R , et al . Model for end‑stage liver disease‑sodium underestimates 90‑day mortality risk in patients with acute‑on‑chronic liver failure [J ] . J Hepatol , 2020 , 73 ( 6 ): 1425 ‑ 1433 .

中国肝移植注册中心 , 国家肝脏移植质控中心 , 国家人体捐献器官获取质控中心 , 等 . 中国移植器官保护专家共识(2022版) [J ] . 武汉大学学报(医学版) , 2022 , 43 ( 3 ): 345 ‑ 359 .

China Liver Transplant Registry, National Center for Healthcare Quality Management in Liver Transplant, National Quality Control Center for Donated Organ Procurement,et al . Chinese Expert Consensus on Organ Protection of Transplantation (2022 edition) [J ] . Medical Journal of Wuhan University , 2022 , 43 ( 3 ): 345 ‑ 359 .

FINKENSTEDT A , NACHBAUR K , ZOLLER H , et al . Acute‑on‑chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait list [J ] . Liver Transpl , 2013 , 19 ( 8 ): 879 ‑ 886 .

SALIBA F , BAÑARES R , LARSEN F S , et al . Artificial liver support in patients with liver failure: A modified DELPHI consensus of international experts [J ] . Intensive Care Med , 2022 , 48 ( 10 ): 1352 ‑ 1367 .

周莉 , 陈煜 . 人工肝治疗肝衰竭模式选择及其疗效判断标准 [J ] . 中华肝脏病杂志 , 2022 ( 2 ): 127 ‑ 130 .

ZHOU L , CHEN Y . Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure [J ] . Chin J Hepatol , 2022 ( 2 ): 127 ‑ 130 .

LARSEN F S . Artificial liver support in acute and acute‑on‑chronic liver failure [J ] . Curr Opin Crit Care , 2019 , 25 ( 2 ): 187 ‑ 191 .

NOVOKHODKO A , HAO S H , AHMAD S , et al . Non‑cell‑based extracorporeal artificial liver systems: Historic perspectives, approaches and mechanisms, current applications, and challenges [J ] . Artif Organs , 2025 , 49 ( 6 ): 925 ‑ 944 .

李兰娟 . 中国人工肝研究: 跟跑者迈向领跑者 [J ] . 中国发明与专利 , 2018 , 15 ( 4 ): 37 ‑ 44 .

LI L J . Artificial liver in China: from follower to leader [J ] . China Invent Pat , 2018 , 15 ( 4 ): 37 ‑ 44 .

BERNAL W , HALL C , KARVELLAS C J , et al . Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure [J ] . Hepatology , 2007 , 46 ( 6 ): 1844 ‑ 1852 .

KEYNES W M . Hæmodialysis in the treatment of liver failure [J ] . Lancet , 1968 , 292 ( 7580 ): 1236 ‑ 1238 .

DENIS J , OPOLON P , NUSINOVICI V , et al . Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane [J ] . Gut , 1978 , 19 ( 9 ): 787 ‑ 793 .

YOSHIBA M , YAMADA H , YOSHIKAWA Y , et al . Hemodiafiltration treatment of deep hepatic Coma by protein passing membrane: Case report [J ] . Artif Organs , 1986 , 10 ( 5 ): 417 ‑ 419 .

CHEVRET L , DURAND P , LAMBERT J , et al . High‑volume hemofiltration in children with acute liver failure [J ] . Pediatr Crit Care Med , 2014 , 15 ( 7 ): e300 ‑ 5 .

中华医学会肝病学分会重型肝病与人工肝学组 . 人工肝血液净化技术临床应用专家共识(2022年版) [J ] . 实用肝脏病杂志 , 2022 , 25 ( 3 ): 457 ‑ 468 .

Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association . Expert consensus on clinical application of artificial liver and blood purification(2022 edition) [J ] . J Pract Hepatol , 2022 , 25 ( 3 ): 457 ‑ 468 .

DAVENPORT A , WILL E J , DAVIDSON A M . Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure [J ] . Crit Care Med , 1993 , 21 ( 3 ): 328 ‑ 338 .

CARDOSO F S , GOTTFRIED M , TUJIOS S , et al . Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure [J ] . Hepatology , 2018 , 67 ( 2 ): 711 ‑ 720 .

THORAT A , JENG L B . Management of renal dysfunction in patients with liver cirrhosis: Role of pretransplantation hemodialysis and outcomes after liver transplantation [J ] . Semin Vasc Surg , 2016 , 29 ( 4 ): 227 ‑ 235 .

WARRILLOW S , FISHER C , TIBBALLS H , et al . Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failure [J ] . Crit Care Resusc , 2020 , 22 ( 2 ): 158 ‑ 165 .

FUJIWARA K , ODA S , ABE R , et al . On‑line hemodiafiltration or high‑flow continuous hemodiafiltration is one of the most effective artificial liver support devices for acute liver failure in Japan [J ] . J Hepato Biliary Pancreat Sci , 2015 , 22 ( 3 ): 246 ‑ 247 .

TAKIKAWA Y , KAKISAKA K , SUZUKI Y , et al . Multicenter study on the consciousness‑regaining effect of a newly developed artificial liver support system in acute liver failure: An on‑line continuous hemodiafiltration system [J ] . Hepatol Res , 2021 , 51 ( 2 ): 216 ‑ 226 .

STANGE J , MITZNER S . A carrier‑mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver [J ] . Int J Artif Organs , 1996 , 19 ( 11 ): 677 ‑ 691 .

BAÑARES R , IBÁÑEZ‑SAMANIEGO L , TORNER J M , et al . Meta‑analysis of individual patient data of albumin dialysis in acute‑on‑chronic liver failure: Focus on treatment intensity [J ] . Therap Adv Gastroenterol , 2019 , 12 : 1756284819879565 .

KANJO A , OCSKAY K , GEDE N , et al . Efficacy and safety of liver support devices in acute and hyperacute liver failure: A systematic review and network meta‑analysis [J ] . Sci Rep , 2021 , 11 ( 1 ): 4189 .

SPONHOLZ C , MATTHES K , RUPP D , et al . Molecular adsorbent recirculating system and single‑pass albumin dialysis in liver failure: A prospective, randomised crossover study [J ] . Crit Care , 2016 , 20 : 2 .

WALLON G , GUTH C , GUICHON C , et al . Extracorporeal albumin dialysis in liver failure with MARS and SPAD: A randomized crossover trial [J ] . Blood Purif , 2022 , 51 ( 3 ): 243 ‑ 250 .

GADOUR E , KABALLO M , SHRWANI K , et al . Safety and efficacy of Single‑Pass Albumin Dialysis (SPAD), Prometheus , and Molecular Adsorbent Recycling System (MARS) liver haemodialysis vs . Standard Medical Therapy (SMT): Meta‑analysis and systematic review [J ] . Przegla̜d Gastroenterologiczny , 2024 , 19 ( 2 ): 101 ‑ 111 .

REEVES H M , WINTERS J L . The mechanisms of action of plasma exchange [J ] . Br J Haematol , 2014 , 164 ( 3 ): 342 ‑ 351 .

KONDRUP J , ALMDAL T , VILSTRUP H , et al . High volume plasma exchange in fulminant hepatic failure [J ] . Int J Artif Organs , 1992 , 15 ( 11 ): 669 ‑ 676 .

LARSEN F S , SCHMIDT L E , BERNSMEIER C , et al . High‑volume plasma exchange in patients with acute liver failure: An open randomised controlled trial [J ] . J Hepatol , 2016 , 64 ( 1 ): 69 ‑ 78 .

MAIWALL R , BAJPAI M , SINGH A , et al . Standard‑volume plasma exchange improves outcomes in patients with acute liver failure: A randomized controlled trial [J ] . Clin Gastroenterol Hepatol , 2022 , 20 ( 4 ): e831 ‑ e854 .

ROLANDO N , WADE J , DAVALOS M , et al . The systemic inflammatory response syndrome in acute liver failure [J ] . Hepatology , 2000 , 32 ( 4 Pt 1 ): 734 ‑ 739 .

BERAN A , MOHAMED M F H , SHAEAR M , et al . Plasma exchange for acute and acute‑on‑chronic liver failure: A systematic review and meta‑analysis [J ] . Liver Transpl , 2024 , 30 ( 2 ): 127 ‑ 141 .

TAN E X , WANG M X , PANG J X , et al . Plasma exchange in patients with acute and acute‑on‑chronic liver failure: A systematic review [J ] . World J Gastroenterol , 2020 , 26 ( 2 ): 219 ‑ 245 .

OCSKAY K , KANJO A , GEDE N , et al . Uncertainty in the impact of liver support systems in acute‑on‑chronic liver failure: A systematic review and network meta‑analysis [J ] . Ann Intensive Care , 2021 , 11 ( 1 ): 10 .

BURKE L , BERNAL W , PIRANI T , et al . Plasma exchange does not improve overall survival in patients with acute liver failure in a real‑world cohort [J ] . J Hepatol , 2025 , 82 ( 4 ): 615 ‑ 621 .

TABEI K , AKAI Y , TAKEDA S , et al . Application of plasma perfusion in hepatic failure [J ] . Biomater Artif Cells Immobilization Biotechnol , 1991 , 19 ( 1 ): 193 ‑ 201 .

WANG T Y , SUN X Y , GUO X , et al . Ultraefficiently calming cytokine storm using Ti 3 C 2 T x MXene [J ] . Small Meth , 2021 , 5 ( 5 ): 2001108 .

POLI E C , RIMMELÉ T , SCHNEIDER A G . Hemoadsorption with CytoSorb ® [J ] . Intensive Care Med , 2019 , 45 ( 2 ): 236 ‑ 239 .

DOMINIK A , STANGE J . Similarities, differences, and potential synergies in the mechanism of action of albumin dialysis using the MARS albumin dialysis device and the CytoSorb hemoperfusion device in the treatment of liver failure [J ] . Blood Purif , 2021 , 50 ( 1 ): 119 ‑ 128 .

中华医学会感染病学分会肝衰竭与人工肝学组 . 非生物型人工肝治疗肝衰竭指南(2016年版) [J ] . 中华临床感染病杂志 , 2016 , 9 ( 2 ): 97 ‑ 103 .

Liver Failure and Artificial Liver Group, Branch of Infectious Diseases, Chinese Medical Association . Guideline for non‑bioartificial liver support systems in treatment of liver failure: 2016 update [J ] . Chin J Clin Infect Dis , 2016 , 9 ( 2 ): 97 ⁃ 103 .

WAN Y M , LI Y H , XU Z Y , et al . Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus‑infected acute‑on‑chronic liver failure treated by entercavir: A prospective study [J ] . J Clin Apher , 2017 , 32 ( 6 ): 453 ‑ 461 .

YAO J , LI S , ZHOU L , et al . Therapeutic effect of double plasma molecular adsorption system and sequential half‑dose plasma exchange in patients with HBV‑related acute‑on‑chronic liver failure [J ] . J Clin Apher , 2019 , 34 ( 4 ): 392 ‑ 398 .

钟珊 , 王娜 , 赵静 , 等 . 血浆置换联合双重血浆吸附治疗提高慢加急性肝衰竭预后 [J ] . 中华肝脏病杂志 , 2018 , 26 ( 10 ): 744 ‑ 749 .

ZHONG S , WANG N , ZHAO J , et al . Plasma exchange combined with double plasma absorption therapy improve the prognosis of acute‑on‑chronic liver failure [J ] . Chin J Hepatol , 2018 , 26 ( 10 ): 744 ‑ 749 .

XIANG Y P , LI R H , CAI J , et al . Three artificial liver models of treatment of acute‑on‑chronic liver failure [J ] . Ther Clin Risk Manag , 2024 , 20 : 731 ‑ 740 .

XU W X , ZHU S , YANG L , et al . Safety and efficacy of double plasma molecular adsorption system with sequential low‑volume plasma exchange in intermediate‑stage hepatitis B virus‑related acute‑on‑chronic liver failure [J ] . J Med Virol , 2023 , 95 ( 3 ): e28650 .

WU S Q , DUAN B , ZENG X P , et al . Construction of blood compatible lysine‑immobilized chitin/carbon nanotube microspheres and potential applications for blood purified therapy [J ] . J Mater Chem B , 2017 , 5 ( 16 ): 2952 ‑ 2963 .

SAIBARA T , MAEDA T , ONISHI S , et al . Plasma exchange and the arterial blood ketone body ratio in patients with acute hepatic failure [J ] . J Hepatol , 1994 , 20 ( 5 ): 617 ‑ 622 .

HOWELL C A , SANDEMAN S R , ZHENG Y , et al . New dextran coated activated carbons for medical use [J ] . Carbon , 2016 , 97 : 134 ‑ 146 .

NAKAE H , EGUCHI Y , SAOTOME T , et al . Multicenter study of plasma diafiltration in patients with acute liver failure [J ] . Ther Apher Dial , 2010 , 14 ( 5 ): 444 ‑ 450 .

ZHANG Y N , DONG R , LI Y , et al . Efficacy and safety of plasma diafiltration: Review of case reports and case series [J ] . Ther Apher Dial , 2023 , 27 ( 1 ): 3 ‑ 11 .

MANNA G L , DONATI G . Coupled plasma filtration adsorption: A multipurpose extracorporeal detoxification therapy [J ] . Blood Purif , 2018 , 46 ( 3 ): 228 ‑ 238 .

DONATI G , CAPELLI I , CROCI CHIOCCHINI A L , et al . Coupled plasma filtration adsorption application for liver and thyroid toxins [J ] . Contrib Nephrol , 2017 , 190 : 31 ‑ 42 .

ZHOU N , LI J Z , ZHANG Y M , et al . Efficacy of coupled low‑volume plasma exchange with plasma filtration adsorption in treating pigs with acute liver failure: A randomised study [J ] . J Hepatol , 2015 , 63 ( 2 ): 378 ‑ 387 .

杨玲玲 . 李氏人工肝治疗乙肝慢加急性肝衰竭疗效的病例对照匹配研究 [D ] . 杭州 : 浙江大学 , 2020 .

YANG L L . Li's artificial liver system improves survival in patients with hepatitis B virus‑related acute‑on‑chronic liver failure: a case‑control matched analysis [D ] . Hangzhou : Zhejiang University , 2020 .

LEE K C L , BAKER L A , STANZANI G , et al . Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre‑clinical study [J ] . J Hepatol , 2015 , 63 ( 3 ): 634 ‑ 642 .

AGARWAL B , CAÑIZARES R B , SALIBA F , et al . Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute‑on‑chronic liver failure [J ] . J Hepatol , 2023 , 79 ( 1 ): 79 ‑ 92 .

OCAK I . A 15‑year retrospective study of supportive extracorporeal therapies including plasma exchange and continuous venovenous hemodiafiltration of 114 adults with acute liver failure awaiting liver transplantation [J ] . Ann Transplant , 2023 , 28 : e939745 .

YANG Z Y , ZHANG Z W , CHENG Q Y , et al . Plasma perfusion combined with plasma exchange in chronic hepatitis B‑related acute‑on‑chronic liver failure patients [J ] . Hepatol Int , 2020 , 14 ( 4 ): 491 ‑ 502 .

MAZARIEGOS G V , PATZER J F , LOPEZ R C , et al . First clinical use of a novel bioartificial liver support system (BLSS) [J ] . Am J Transplant , 2002 , 2 ( 3 ): 260 ‑ 266 .

CHAMULEAU R A , POYCK P P , VAN DE KERKHOVE M P . Bioartificial liver: Its pros and cons [J ] . Ther Apher Dial , 2006 , 10 ( 2 ): 168 ‑ 174 .

FRÜHAUF J H , MERTSCHING H , GIRI S , et al . Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells [J ] . Liver Int , 2009 , 29 ( 10 ): 1553 ‑ 1561 .

STRAIN A J . Isolated hepatocytes: Use in experimental and clinical hepatology [J ] . Gut , 1994 , 35 ( 4 ): 433 ‑ 436 .

THOMPSON J , JONES N , AL‑KHAFAJI A , et al . Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial [J ] . Liver Transplant , 2018 , 24 ( 3 ): 380 ‑ 393 .

TANG N H , WANG X Q , LI X J , et al . Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase [J ] . Hepatobiliary Pancreat Dis Int , 2008 , 7 ( 6 ): 621 ‑ 627 .

NIBOURG G A A , HUISMAN M T , VAN DER HOEVEN T V , et al . Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application [J ] . Liver Transpl , 2010 , 16 ( 9 ): 1075 ‑ 1085 .

KOBAYASHI N , FUJIWARA T , WESTERMAN K A , et al . Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes [J ] . Science , 2000 , 287 ( 5456 ): 1258 ‑ 1262 .

FENG L , WANG Y , FU Y , et al . Stem cell‑based strategies: The future direction of bioartificial liver development [J ] . Stem Cell Rev Rep , 2024 , 20 ( 3 ): 601 ‑ 616 .

CHEN S T , WANG J L , REN H Z , et al . Hepatic spheroids derived from human induced pluripotent stem cells in bio‑artificial liver rescue porcine acute liver failure [J ] . Cell Res , 2020 , 30 ( 1 ): 95 ‑ 97 .

WANG Y F , ZHENG Q , SUN Z , et al . Reversal of liver failure using a bioartificial liver device implanted with clinical‑grade human‑induced hepatocytes [J ] . Cell Stem Cell , 2023 , 30 ( 5 ): 617 ‑ 631.e8 .

STRAIN A J , NEUBERGER J M . A bioartificial liver: State of the art [J ] . Science , 2002 , 295 ( 5557 ): 1005 ‑ 1009 .

WENG J , HAN X , ZENG F H , et al . Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs [J ] . Theranostics , 2021 , 11 ( 16 ): 7620 ‑ 7639 .

GLORIOSO J M , MAO S A , RODYSILL B , et al . Pivotal preclinical trial of the spheroid reservoir bioartificial liver [J ] . J Hepatol , 2015 , 63 ( 2 ): 388 ‑ 398 .

CHEN H S , JOO D J , SHAHEEN M , et al . Randomized trial of spheroid reservoir bioartificial liver in porcine model of posthepatectomy liver failure [J ] . Hepatology , 2019 , 69 ( 1 ): 329 ‑ 342 .

ZHOU P C , SHAO L , ZHAO L F , et al . Efficacy of fluidized bed bioartificial liver in treating fulminant hepatic failure in pigs: A metabolomics study [J ] . Sci Rep , 2016 , 6 : 26070 .

CHU X H , SHI X L , FENG Z Q , et al . In vitro evaluation of a multi‑layer radial‑flow bioreactor based on galactosylated chitosan nanofiber scaffolds [J ] . Biomaterials , 2009 , 30 ( 27 ): 4533 ‑ 4538 .

PARK J , LI Y W , BERTHIAUME F , et al . Radial flow hepatocyte bioreactor using stacked microfabricated grooved substrates [J ] . Biotechnol Bioeng , 2008 , 99 ( 2 ): 455 ‑ 467 .

LU T L , LI Y H , CHEN T . Techniques for fabrication and construction of three‑dimensional scaffolds for tissue engineering [J ] . Int J Nanomed , 2013 , 8 : 337 ‑ 350 .

VERMA S K , MODI A , BELLARE J . Three‑dimensional multiscale fiber matrices: Development and characterization for increased HepG2 functional maintenance for bio‑artificial liver application [J ] . Biomater Sci , 2018 , 6 ( 2 ): 280 ‑ 291 .

CHEN A K , REUVENY S , OH S K W . Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future direction [J ] . Biotechnol Adv , 2013 , 31 ( 7 ): 1032 ‑ 1046 .

DUAN B , ZHENG X , XIA Z X , et al . Highly biocompatible nanofibrous microspheres self‑assembled from chitin in NaOH/urea aqueous solution as cell carriers [J ] . Angew Chem Int Ed , 2015 , 54 ( 17 ): 5152 ‑ 5156 .

ZHANG S , MA B J , WANG S C , et al . Mass‑production of fluorescent chitosan/graphene oxide hybrid microspheres for in vitro 3D expansion of human umbilical cord mesenchymal stem cells [J ] . Chem Eng J , 2018 , 331 : 675 ‑ 684 .

LEE D J , LEE K , CHA C . Microfluidics‑assisted fabrication of microtissues with tunable physical properties for developing an in vitro multiplex tissue model [J ] . Adv Biosyst , 2018 , 2 ( 12 ): 1800236 .

TUERXUN K , HE J Y , IBRAHIM I , et al . Bioartificial livers: A review of their design and manufacture [J ] . Biofabrication , 2022 , 14 ( 3 ): 032003 .

HE Y T , QI Y N , ZHANG B Q , et al . Bioartificial liver support systems for acute liver failure: A systematic review and meta‑analysis of the clinical and preclinical literature [J ] . World J Gastroenterol , 2019 , 25 ( 27 ): 3634 ‑ 3648 .

YU C B , PAN X P , YU L , et al . Evaluation of a novel choanoid fluidized bed bioreactor for future bioartificial livers [J ] . World J Gastroenterol , 2014 , 20 ( 22 ): 6869 ‑ 6877 .

WATANABE F D , MULLON C J , HEWITT W R , et al . Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase Ⅰ clinical trial [J ] . Ann Surg , 1997 , 225 ( 5 ): 484‑491;discussion 491‑494 .

DEMETRIOU A A , BROWN R S , BUSUTTIL R W , et al . Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure [J ] . Ann Surg , 2004 , 239 ( 5 ): 660‑667;discussion 667‑670 .

SAUER I M , ZEILINGER K , OBERMAYER N , et al . Primary human liver cells as source for modular extracorporeal liver support–A preliminary report [J ] . Int J Artif Organs , 2002 , 25 ( 10 ): 1001 ‑ 1005 .

FLENDRIG L M , LA SOE J W , JÖRNING G G , et al . In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates [J ] . J Hepatol , 1997 , 26 ( 6 ): 1379 ‑ 1392 .

VAN DE KERKHOVE M P , DI FLORIO E , SCUDERI V , et al . Phase Ⅰ clinical trial with the AMC‑bioartificial liver [J ] . Int J Artif Organs , 2002 , 25 ( 10 ): 950 ‑ 959 .

QIAN Y , LANJUAN L , JIANRONG H , et al . Study of severe hepatitis treated with a hybrid artificial liver support system [J ] . Int J Artif Organs , 2003 , 26 ( 6 ): 507 ‑ 513 .